La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Evaxion a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Evaxion..

Evaxion (NASDAQ:EVAX) Azioni, Catena delle Opzioni

EVAXION A/S

Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

AREN

CSTM

EVAX

GDYN

GEAR

VIRX

Le azioni di Constellium, Viracta, Evaxion, Arena e Grid Dynamics mostrano movimenti significativi nella sessione di pre-market di oggi.

Pre-market: 5 titoli da monitorare oggi, 27 dicembre 2024

Evaxion AS

Financing

Press Releases

Evaxion finalizes agreement with EIB to convert debt into equity

Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

Small Cap

Opinion

Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments

Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025

Evaxion announces business update and second quarter 2025 financial results

Evaxion to present at several conferences during the second half of 2025

Penny Stocks

Evaxion out-licenses vaccine candidate EVX-B3 to MSD

Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting

Evaxion expands AI-Immunology™ platform with automated vaccine design module

Biotech

General

Evaxion to present a breadth of data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

AGEN

CELC

LYEL

ONCY

TSX:ONC

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

BioAtla

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

Celularity

Equillium

Evaxion

FibroGen

Generation Bio

INmune Bio

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Lantern Pharma

MAIA Biotechnology

Medicus Pharma

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

Q32 Bio

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Serina Therapeutics

Skye Bioscience

Senti Biosciences

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

HC Wainwright & Co.

Lake Street

Ladenburg Thalmann

Oppenheimer

Comments

Evaxion

Evaxion (EVAX) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO